Waksal Harlan
- SEC CIK
- 0001449008
No open-market purchases or sales filed in the past year.
Current role at each company
- FRNM Freenome, Inc.Other: Former Directoras of Jul 29, 2026
- LYRA Lyra Therapeutics, Inc.Executive Chairas of Dec 11, 2024
- KDMN Kadmon Holdings, Inc.President, CEOas of Nov 9, 2021
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Waksal Harlan as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
LYRA Lyra Therapeutics, Inc.
Executive Chair2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 13, 2023 (view filing) | Nov 10 | 3 days | Waksal HarlanExecutive Chair | PPurchase | +25.0K | $2.96 | +$74.0K | +10.6%262.0K after | |
| Apr 13, 2022 (view filing) | Apr 12 | 1 day | Waksal HarlanExecutive Chair | PPurchase | +237.0K | $4.22 | +$1.00M | New position237.0K after |